Citius Pharmaceuticals, Inc. — Investor Relations & Filings
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company that develops and commercializes critical care products. The company's diversified pipeline focuses on anti-infectives in adjunct cancer care, stem cell therapies, and prescription products. Its portfolio includes LYMPHIR™, an FDA-approved therapy for adult patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Key product candidates in development include Mino-Lok®, an antibiotic lock solution intended to treat patients with catheter-related bloodstream infections, and Halo-Lido, a topical formulation for the treatment of hemorrhoids. Additionally, the company is advancing a stem cell therapy platform for conditions such as acute respiratory distress syndrome (ARDS).
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| CURRENT REPORT | 2026-06-01 | English | |
| REGISTRATION STATEMENT | 2026-05-22 | English | |
| CURRENT REPORT | 2026-05-15 | English | |
| QUARTERLY REPORT | 2026-05-15 | English | |
| 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English | |
| 424B5 - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47923554 | CURRENT REPORT | 2026-06-01 | English | ||
| 46860857 | REGISTRATION STATEMENT | 2026-05-22 | English | ||
| 46362590 | CURRENT REPORT | 2026-05-15 | English | ||
| 46363360 | QUARTERLY REPORT | 2026-05-15 | English | ||
| 36278647 | 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English | ||
| 36137720 | 424B5 - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-24 | English | ||
| 33641001 | 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-04-06 | English | ||
| 33122239 | 8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer) | 2026-03-31 | English | ||
| 32892870 | 8-K - CITIUS PHARMACEUTICALS, INC. (0001506251) (Filer) | 2026-03-04 | English | ||
| 32892869 | ARS - CITIUS PHARMACEUTICALS, INC. (0001506251) (Filer) | 2026-02-24 | English | ||
| 32892871 | DEF 14A - CITIUS PHARMACEUTICALS, INC. (0001506251) (Filer) | 2026-02-24 | English | ||
| 30211696 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30211698 | 10-Q Filing | 2026-02-13 | English | ||
| 30211695 | 8-K Filing | 2026-02-13 | English | ||
| 30211697 | 10-K/A Filing | 2026-01-28 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Develops and manufactures IVD reagents and vaccines for inf…
|
603392 | CN | Manufacturing |
|
Beleave Inc.
Vertically integrated cannabis company engaged in cultivati…
|
BLEVF | CA | Manufacturing |
|
BELITE BIO, INC
Clinical-stage biopharma developing therapies for retinal a…
|
BLTE | KY | Manufacturing |
|
Benitec Biopharma Inc.
A clinical-stage biotech developing genetic medicines to si…
|
BNTC | US | Manufacturing |
|
BeOne Medicines Ltd.
Global oncology company that discovers, develops, and deliv…
|
ONC | KY | Manufacturing |
|
BEONE MEDICINES LTD.
Biopharmaceutical firm developing targeted oncology therapi…
|
688235 | CN | Manufacturing |
|
BerGenBio
Clinical-stage biopharma that developed selective AXL kinas…
|
BGBIO | NO | Manufacturing |
|
Beryl Drugs Ltd.
Manufactures IV fluids and small volume parenterals for cli…
|
524606 | IN | Manufacturing |
|
BESHOM HOLDINGS BERHAD
An investment holding company with diversified operations i…
|
— | MY | Manufacturing |
|
Besunyen Holdings Company Limited
Leading supplier of functional health teas, weight manageme…
|
926 | HK | Manufacturing |
Citius Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34965/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34965 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34965 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34965 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34965}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Citius Pharmaceuticals, Inc. (id: 34965)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.